Aethlon Medical (AEMD) Assets Growth (3y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Aethlon Medical | 1.14 Mn | -5.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -27.02% |
| Sep 30, 2025 | -31.76% |
| Jun 30, 2025 | -32.34% |
| Mar 31, 2025 | -27.63% |
| Dec 31, 2024 | -33.23% |
| Sep 30, 2024 | -28.17% |
| Jun 30, 2024 | -23.87% |
| Mar 31, 2024 | -8.23% |
| Dec 31, 2023 | -6.26% |
| Sep 30, 2023 | -5.20% |
| Jun 30, 2023 | -1.29% |
| Mar 31, 2023 | 19.01% |
| Dec 31, 2022 | 64.19% |
| Sep 30, 2022 | 161.98% |
| Jun 30, 2022 | 80.10% |
| Mar 31, 2022 | 67.62% |
| Dec 31, 2021 | 64.20% |
| Sep 30, 2021 | 65.44% |
| Jun 30, 2021 | 58.85% |
| Mar 31, 2021 | 13.22% |
| Dec 31, 2020 | 30.12% |
| Sep 30, 2020 | 135.97% |
| Jun 30, 2020 | 218.35% |
| Mar 31, 2020 | 81.88% |
| Dec 31, 2019 | 81.00% |
| Sep 30, 2019 | 10.47% |
| Jun 30, 2019 | 26.15% |
| Mar 31, 2019 | 17.69% |
| Dec 31, 2018 | 11.28% |
| Sep 30, 2018 | 3.86% |
| Jun 30, 2018 | 2.61% |
| Mar 31, 2018 | 74.63% |
| Dec 31, 2017 | 22.13% |
| Sep 30, 2017 | 1.71% |
| Jun 30, 2017 | -23.66% |
| Mar 31, 2017 | 0.61% |
| Dec 31, 2016 | -27.88% |
| Sep 30, 2016 | 32.24% |
| Jun 30, 2016 | 95.60% |
| Mar 31, 2016 | 72.04% |
| Dec 31, 2015 | 127.02% |
| Sep 30, 2015 | 114.81% |
| Jun 30, 2015 | 93.64% |
| Mar 31, 2015 | 18.07% |
| Dec 31, 2014 | 51.76% |
| Sep 30, 2014 | 49.94% |
| Jun 30, 2014 | 52.60% |
| Mar 31, 2014 | 44.04% |